Krebs Biochemicals and Industries Limited — Others, 02-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Krebs Biochemicals & Industries Limited has submitted certificates from KFIN Technologies indicating the details of securities dematerialized and rematerialized for the quarter ended December 31, 2024. These documents confirm compliance with SEBI regulations and have been sent to all relevant stock exchanges. This update reflects effective management of company securities and adherence to regulatory standards, potentially enhancing investor confidence. Overall, it supports a positive outlook for operational transparency and shareholder relations, while maintaining a neutral impact on stock performance expectations.